Homogeneous catalytic activation of vinylic carbon-hydrogen bonds. Stereoselective hydrogen-deuterium exchange in neohexene

1985 ◽  
Vol 4 (8) ◽  
pp. 1488-1490 ◽  
Author(s):  
J. W. Faller ◽  
Hugh. Felkin
Keyword(s):  
Hydrogen Bonds ◽  
Deuterium Exchange ◽  
Hydrogen Deuterium Exchange ◽  
Catalytic Activation ◽  
Hydrogen Deuterium ◽  
Carbon Hydrogen Bonds

scholarly journals Dynamics of Cleft Closure of the GluA2 Ligand-binding Domain in the Presence of Full and Partial Agonists Revealed by Hydrogen-Deuterium Exchange

2013 ◽  
Vol 288 (38) ◽  
pp. 27658-27666 ◽  
Author(s):  
Ahmed H. Ahmed ◽  
Christopher P. Ptak ◽  
Michael K. Fenwick ◽  
Ching-Lin Hsieh ◽  
Gregory A. Weiland ◽  
...  
Keyword(s):  
Hydrogen Bonds ◽  
Ligand Binding ◽  
Binding Domain ◽  
Deuterium Exchange ◽  
Ligand Binding Domain ◽  
Hydrogen Deuterium Exchange ◽  
Channel Activation ◽  
Hydrogen Deuterium ◽  
Cleft Closure ◽  
The Stability

The majority of excitatory neurotransmission in the CNS is mediated by tetrameric AMPA receptors. Channel activation begins with a series of interactions with an agonist that binds to the cleft between the two lobes of the ligand-binding domain of each subunit. Binding leads to a series of conformational transitions, including the closure of the two lobes of the binding domain around the ligand, culminating in ion channel opening. Although a great deal has been learned from crystal structures, determining the molecular details of channel activation, deactivation, and desensitization requires measures of dynamics and stabilities of hydrogen bonds that stabilize cleft closure. The use of hydrogen-deuterium exchange at low pH provides a measure of the variation of stability of specific hydrogen bonds among agonists of different efficacy. Here, we used NMR measurements of hydrogen-deuterium exchange to determine the stability of hydrogen bonds in the GluA2 (AMPA receptor) ligand-binding domain in the presence of several full and partial agonists. The results suggest that the stabilization of hydrogen bonds between the two lobes of the binding domain is weaker for partial than for full agonists, and efficacy is correlated with the stability of these hydrogen bonds. The closure of the lobes around the agonists leads to a destabilization of the hydrogen bonding in another portion of the lobe interface, and removing an electrostatic interaction in Lobe 2 can relieve the strain. These results provide new details of transitions in the binding domain that are associated with channel activation and desensitization.

Sign in / Sign up

Export Citation Format

Share Document